Inotiv, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Robert W. Leasure Jr., with a market cap of $7.9M.
Common questions about Inotiv, Inc.
Inotiv, Inc. is scheduled to report earnings for Q2 2026 on May 6, 2026. Analysts estimate revenue of $124.7M.
Inotiv, Inc. has approximately 2,055 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.